ARTV – artiva biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its price target lowered by analysts at Cantor Fitzgerald from $23.00 to $20.00. They now have an "overweight" rating on the stock.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Form 10-K Artiva Biotherapeutics, For: Dec 31
Form 8-K Artiva Biotherapeutics, For: Mar 24
Form 4 Artiva Biotherapeutics, For: Mar 05 Filed by: Aslan Fred
Form 4 Artiva Biotherapeutics, For: Feb 26 Filed by: Horan Christopher
Form 4 Artiva Biotherapeutics, For: Feb 26 Filed by: Raymon Heather
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.